Profluent Bio
PrivateLast Round
Series B
Nov 19, 2025
Est. Valuation
$975M
Total Funding Raised
$362M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Profluent Bio is a biotechnology company that develops artificial intelligence-based models to design and validate novel, functional proteins for human health and industrial applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Profluent Bio Comparables
Compare Profluent Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evozyne | 88% | |
| Generate Biomedicines | 86% | |
| EvolutionaryScale | 85% |
Profluent Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 19, 2025 | ||||
| Early Funding | Nov 19, 2025 | ||||
| Series B | May 22, 2024 | ||||
| Series A | Mar 21, 2024 | ||||
| Seed | Jan 26, 2023 |
Profluent Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Air Street Capital | Series B, Early Funding, Seed, Series A |
| Bezos Expeditions | Series B, Early Funding |
| Convergent Ventures | Seed |
| Spark Capital | Series B, Early Funding, Series A |
| AIX Ventures | Seed |
| Insight Partners | Series B, Early Funding, Series A, Seed |
| Altimeter Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Grew 17% QoQ, from 64 to 75 employees.
- Jul 27, 2026
Monthly visitors increased 46% MoM.
Profluent Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Profluent Bio's valuation, stock price, and market status.
Is Profluent Bio a public or private company?
Profluent Bio is a private company.
What is the current stock price of Profluent Bio?
Profluent Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Profluent Bio worth (valuation)?
Profluent Bio's valuation is estimated at $1.0B based on funding round data.
Can I buy Profluent Bio stock?
Profluent Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Profluent Bio's last funding round?
Profluent Bio's most recent funding round was Early Funding on November 19, 2025.
Who are the main investors in Profluent Bio?
Key investors in Profluent Bio include Bezos Expeditions, Spark Capital, Insight Partners, Altimeter Capital Management.
Will Profluent Bio IPO soon?
No public IPO plans have been announced for Profluent Bio.
How can I track Profluent Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Profluent Bio's secondary market activity and sign up for updates.